IUPAC and Gedeon Richter, Plc. are pleased to announce the 2024 IUPAC-Richter Prize in Medicinal Chemistry. The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery. It is endowed with USD 10’000.
The 2026 IUPAC-Richter Prize will be presented during the 39th ACS National Medicinal Chemistry Symposium (May 31-June 3, 2026) in Atlanta, GA, United States and the recipient will also give a lecture on the subject of their research at the XXIXth EFMC International Symposium on Medicinal Chemistry (September 6-10, 2026) in Basel, Switzerland.
Applications are by nomination, with only one person needing to serve in that capacity, although a total of five individuals should additionally be listed as references. The nomination package must be submitted via this form and should contain:
- a complete resume,
- a professional biography of not more than two pages, and
- a one-page summary of what the individual considers to be their activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry.
Nomination materials should be uploaded by 15 December 2025 to IUPAC Secretariat via the following online form: https://www.cognitoforms.com/IUPAC1/IUPACRichterPrize2026NominationForm
The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Drug Discovery and Development.
For further information please contact Prof. Janos Fischer, Member of the IUPAC Sub-committee on Drug Discovery and Development, by email at
David Spichiger, SCS
15.07.2025